カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Measles, Mumps and Rubella Virus Vaccine Live Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7922）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7922
■ 発行日：2023年9月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：79
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥494,160見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥741,240見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥988,320見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界の麻疹・おたふく風邪・風疹ウイルス生ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 麻疹・おたふく風邪・風疹ウイルス生ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

麻疹・おたふく風邪・風疹ウイルス生ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・子供、大人

用途別セグメント
・病院、地域

主要な市場プレーヤー
・Merck、Shanghai Institute of Biological Products、Beijing Tiantan Biological Products

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、麻疹・おたふく風邪・風疹ウイルス生ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な麻疹・おたふく風邪・風疹ウイルス生ワクチンメーカーの企業概要、2019年～2022年までの麻疹・おたふく風邪・風疹ウイルス生ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な麻疹・おたふく風邪・風疹ウイルス生ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別麻疹・おたふく風邪・風疹ウイルス生ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの麻疹・おたふく風邪・風疹ウイルス生ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での麻疹・おたふく風邪・風疹ウイルス生ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および麻疹・おたふく風邪・風疹ウイルス生ワクチンの産業チェーンを掲載しています。
・第14、15章では、麻疹・おたふく風邪・風疹ウイルス生ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 麻疹・おたふく風邪・風疹ウイルス生ワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：子供、大人
– 用途別分析（2018年vs2022年vs2029年）：病院、地域
– 世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場規模・予測
– 世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Shanghai Institute of Biological Products、Beijing Tiantan Biological Products
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：子供、大人
・用途別分析2018年-2029年：病院、地域
・麻疹・おたふく風邪・風疹ウイルス生ワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・麻疹・おたふく風邪・風疹ウイルス生ワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・麻疹・おたふく風邪・風疹ウイルス生ワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・麻疹・おたふく風邪・風疹ウイルス生ワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・麻疹・おたふく風邪・風疹ウイルス生ワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Measles, Mumps and Rubella Virus Vaccine Live
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Child
1.3.3 Adult
1.4 Market Analysis by Application
1.4.1 Overview: Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Community
1.5 Global Measles, Mumps and Rubella Virus Vaccine Live Market Size & Forecast
1.5.1 Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity (2018-2029)
1.5.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measles, Mumps and Rubella Virus Vaccine Live Product and Services
2.1.4 Merck Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Shanghai Institute of Biological Products
2.2.1 Shanghai Institute of Biological Products Details
2.2.2 Shanghai Institute of Biological Products Major Business
2.2.3 Shanghai Institute of Biological Products Measles, Mumps and Rubella Virus Vaccine Live Product and Services
2.2.4 Shanghai Institute of Biological Products Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Shanghai Institute of Biological Products Recent Developments/Updates
2.3 Beijing Tiantan Biological Products
2.3.1 Beijing Tiantan Biological Products Details
2.3.2 Beijing Tiantan Biological Products Major Business
2.3.3 Beijing Tiantan Biological Products Measles, Mumps and Rubella Virus Vaccine Live Product and Services
2.3.4 Beijing Tiantan Biological Products Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing Tiantan Biological Products Recent Developments/Updates
3 Competitive Environment: Measles, Mumps and Rubella Virus Vaccine Live by Manufacturer
3.1 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Manufacturer (2018-2023)
3.2 Global Measles, Mumps and Rubella Virus Vaccine Live Revenue by Manufacturer (2018-2023)
3.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Measles, Mumps and Rubella Virus Vaccine Live by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Measles, Mumps and Rubella Virus Vaccine Live Manufacturer Market Share in 2022
3.4.2 Top 6 Measles, Mumps and Rubella Virus Vaccine Live Manufacturer Market Share in 2022
3.5 Measles, Mumps and Rubella Virus Vaccine Live Market: Overall Company Footprint Analysis
3.5.1 Measles, Mumps and Rubella Virus Vaccine Live Market: Region Footprint
3.5.2 Measles, Mumps and Rubella Virus Vaccine Live Market: Company Product Type Footprint
3.5.3 Measles, Mumps and Rubella Virus Vaccine Live Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Measles, Mumps and Rubella Virus Vaccine Live Market Size by Region
4.1.1 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2018-2029)
4.1.2 Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2018-2029)
4.1.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Region (2018-2029)
4.2 North America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
4.3 Europe Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
4.4 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
4.5 South America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
4.6 Middle East and Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
5.2 Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Type (2018-2029)
5.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
6.2 Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Application (2018-2029)
6.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Application (2018-2029)
7 North America
7.1 North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
7.2 North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
7.3 North America Measles, Mumps and Rubella Virus Vaccine Live Market Size by Country
7.3.1 North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2029)
7.3.2 North America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
8.2 Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
8.3 Europe Measles, Mumps and Rubella Virus Vaccine Live Market Size by Country
8.3.1 Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2029)
8.3.2 Europe Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Market Size by Region
9.3.1 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
10.2 South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
10.3 South America Measles, Mumps and Rubella Virus Vaccine Live Market Size by Country
10.3.1 South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2029)
10.3.2 South America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Market Size by Country
11.3.1 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Measles, Mumps and Rubella Virus Vaccine Live Market Drivers
12.2 Measles, Mumps and Rubella Virus Vaccine Live Market Restraints
12.3 Measles, Mumps and Rubella Virus Vaccine Live Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Measles, Mumps and Rubella Virus Vaccine Live and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measles, Mumps and Rubella Virus Vaccine Live
13.3 Measles, Mumps and Rubella Virus Vaccine Live Production Process
13.4 Measles, Mumps and Rubella Virus Vaccine Live Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measles, Mumps and Rubella Virus Vaccine Live Typical Distributors
14.3 Measles, Mumps and Rubella Virus Vaccine Live Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Measles, Mumps and Rubella Virus Vaccine Live Product and Services
Table 6. Merck Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Shanghai Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 9. Shanghai Institute of Biological Products Major Business
Table 10. Shanghai Institute of Biological Products Measles, Mumps and Rubella Virus Vaccine Live Product and Services
Table 11. Shanghai Institute of Biological Products Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Shanghai Institute of Biological Products Recent Developments/Updates
Table 13. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
Table 14. Beijing Tiantan Biological Products Major Business
Table 15. Beijing Tiantan Biological Products Measles, Mumps and Rubella Virus Vaccine Live Product and Services
Table 16. Beijing Tiantan Biological Products Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Beijing Tiantan Biological Products Recent Developments/Updates
Table 18. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 19. Global Measles, Mumps and Rubella Virus Vaccine Live Revenue by Manufacturer (2018-2023) & (USD Million)
Table 20. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Market Position of Manufacturers in Measles, Mumps and Rubella Virus Vaccine Live, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 22. Head Office and Measles, Mumps and Rubella Virus Vaccine Live Production Site of Key Manufacturer
Table 23. Measles, Mumps and Rubella Virus Vaccine Live Market: Company Product Type Footprint
Table 24. Measles, Mumps and Rubella Virus Vaccine Live Market: Company Product Application Footprint
Table 25. Measles, Mumps and Rubella Virus Vaccine Live New Market Entrants and Barriers to Market Entry
Table 26. Measles, Mumps and Rubella Virus Vaccine Live Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2018-2023) & (K Units)
Table 28. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2024-2029) & (K Units)
Table 29. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2018-2023) & (USD Million)
Table 30. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2024-2029) & (USD Million)
Table 31. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Region (2018-2023) & (US$/Unit)
Table 32. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Region (2024-2029) & (US$/Unit)
Table 33. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2023) & (K Units)
Table 34. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2024-2029) & (K Units)
Table 35. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Type (2018-2023) & (US$/Unit)
Table 38. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Type (2024-2029) & (US$/Unit)
Table 39. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2024-2029) & (K Units)
Table 41. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Application (2018-2023) & (USD Million)
Table 42. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Application (2024-2029) & (USD Million)
Table 43. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Application (2018-2023) & (US$/Unit)
Table 44. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Application (2024-2029) & (US$/Unit)
Table 45. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2023) & (K Units)
Table 46. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2024-2029) & (K Units)
Table 47. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2023) & (K Units)
Table 48. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2024-2029) & (K Units)
Table 49. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2023) & (K Units)
Table 50. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2024-2029) & (K Units)
Table 51. North America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2023) & (USD Million)
Table 52. North America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2023) & (K Units)
Table 56. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2024-2029) & (K Units)
Table 57. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2023) & (K Units)
Table 58. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2024-2029) & (K Units)
Table 59. Europe Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2023) & (K Units)
Table 62. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2024-2029) & (K Units)
Table 63. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2023) & (K Units)
Table 64. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2024-2029) & (K Units)
Table 65. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2018-2023) & (K Units)
Table 66. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2024-2029) & (K Units)
Table 67. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2018-2023) & (USD Million)
Table 68. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2024-2029) & (USD Million)
Table 69. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2023) & (K Units)
Table 70. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2024-2029) & (K Units)
Table 71. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2023) & (K Units)
Table 72. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2024-2029) & (K Units)
Table 73. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2023) & (K Units)
Table 74. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2024-2029) & (K Units)
Table 75. South America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2023) & (USD Million)
Table 76. South America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2024-2029) & (USD Million)
Table 77. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2023) & (K Units)
Table 78. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2024-2029) & (K Units)
Table 79. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2018-2023) & (K Units)
Table 82. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2024-2029) & (K Units)
Table 83. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2018-2023) & (USD Million)
Table 84. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2024-2029) & (USD Million)
Table 85. Measles, Mumps and Rubella Virus Vaccine Live Raw Material
Table 86. Key Manufacturers of Measles, Mumps and Rubella Virus Vaccine Live Raw Materials
Table 87. Measles, Mumps and Rubella Virus Vaccine Live Typical Distributors
Table 88. Measles, Mumps and Rubella Virus Vaccine Live Typical Customers
List of Figures
Figure 1. Measles, Mumps and Rubella Virus Vaccine Live Picture
Figure 2. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Type in 2022
Figure 4. Child Examples
Figure 5. Adult Examples
Figure 6. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Community Examples
Figure 10. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Measles, Mumps and Rubella Virus Vaccine Live by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Measles, Mumps and Rubella Virus Vaccine Live Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Measles, Mumps and Rubella Virus Vaccine Live Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Region (2018-2029)
Figure 52. China Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Measles, Mumps and Rubella Virus Vaccine Live Market Drivers
Figure 73. Measles, Mumps and Rubella Virus Vaccine Live Market Restraints
Figure 74. Measles, Mumps and Rubella Virus Vaccine Live Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Measles, Mumps and Rubella Virus Vaccine Live in 2022
Figure 77. Manufacturing Process Analysis of Measles, Mumps and Rubella Virus Vaccine Live
Figure 78. Measles, Mumps and Rubella Virus Vaccine Live Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • はしか・おたふく風邪・風疹ウイルスワクチンの世界市場2025年：こども用、大人用
  • 世界の弱毒生日本脳炎ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の五価ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のアフリカ豚コレラウイルス検出キット市場2023年：企業・地域・タイプ・用途別分析
  • 世界のスプリット・インフルエンザ・ワクチン市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7922 )"世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Measles, Mumps and Rubella Virus Vaccine Live Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。